Rolling broadcast the fourth round of state-owned bidding pharmaceutical company quotations updated in real time

Annex: The fourth batch of national mining competition pattern (Source: Insight database) "The fourth batch of national mining field enterprise quotation real-time update" 1, Esomeprazole magnesium intestinal solution 20mg 30 pieces Zhengda Tianqing 84.73 yuan 2, ammonia pill 3, hydrochloride bromine injection 2ml: 15mg 2 0 Colum Pharmaceuticals 6.76 yuan 4, hydrochloric acid olotatin eye drops 5mL: 5mg (0.1%) Novartis Pharma 81.17 yuan 5, pyridamide tablets 6, propofol medium/long chain fat emulsion 20ml:0.2g 4 Yangzijiang Pharmaceuticals 50 yuan single Jiangsu Yingke 13.4 yuan single Colum Pharmaceuticals 14.9 yuan single Feisen Yuscabi 9.9 yuan single German Belang 15.5 yuan 7, ibuprofen tablets 8, ibuprofen injection 9, hydrochloric acid loxitin intestinal capsules 10, doso-tea-alkali injection 11, Engele net tablets 10mg 10 tablets Colum Pharmaceuticals 18.3 yuan 30 tablets Zheng day sunny 55.64 yuan 12, Entourathamantinofowe tablets 200mg:300mg 10 pieces Hesco 220 yuan 30 pieces positive day sunny 666 yuan 13, Grezit slow release tablets 14, Gabba spray capsule 15, Kagle net tablets 0.1g 30 pieces positive day sunny 52.99 yuan 16, fumarate quinine sulfur flat release tablets 200mg 20 pieces Asli Kang 76.9 yuan Fumaric acid sulfur flat release tablets 50mg 20 tablets Foshan Dexter Pharmaceuticals 24.17 yuan 17, Losolofen sodium tablets 18, chlororeta tablets 19, chloretamine tablets 19, sodium acid moshabili tablets 20, Naglinai tablets 120mg 12 pieces Novartic Pharmaceutical 14.16 yuan 21, injection of Parexib sodium 20mg 1 piece Nanjing Zhengda Tianqing 4.49 yuan injection with Parechib sodium 40mg 1 Pfizer 88.38 yuan 10 Colum Pharmaceuticals 56.40 yuan 22, sodium sodium intestinal solution 2 3, injection of sodium 40mg 6 pieces Of Yangzijiang Pharmaceuticals 23.4 24, 4mg 21 tablets of Heske: 15.12 25, injection of boron tezome 1mg Nanjing Zhengda Tianqing no quotation 1 zhengdaTianqing 346 yuan 26, Hydrochloric acid Prakso slow release tablets 0.375g 7 pieces Hesco: 15.4 27, hydrochloric acid Prakso tablets 0.25mg 30 tablets Qilu Pharmaceuticals 11.4 yuan 28, Pribarin capsules 75mg 32 tablets Qiru Pharmaceuticals 10.24 yuan 20 pieces Chongqing Sai Vi 43.7 yuan 29, hydroxybenzene calcium capsule 30, reglinai tablets 31, toluene sulfonate tablets 32, tigrelo tablets 60mg 20 pieces Hesco: 50.20 14 pieces Nanjing Zhengda Tianqing 12.88 yuan 33, Timisha Tan tablets 34, tymoamine capsules 35, inhaled salbonamine solution 36, prostatin ammonia chloride tablets (I.) 80mg: 5mg 7 tablets Novartis Pharmaceuticals 42.7 yuan 37, salatan hydrochloride tablets 80mg: 12.5mg 7 tablets Novartis Pharmaceuticals 15.96 yuan 38, voliconazole tablets 200mg 10 pieces Pfizer 2580 yuan 39, nofluorosa star capsule 40, hydrochloric acid tebifen tablets 41, cephalosporine tablets 0.25g 20 pieces Yangzijiang Pharmaceuticals 21.6 yuan 42, Left oxyfluorosa star slice 43, sodium chlorate eye drops 5ml: 5mg (0.1%) 5ml Jiangxi Cherish Ming Pharmaceuticals 5.8 yuan sodium glass acid eye drops 10ml: 10mg (0.1%) 10ml Zhongshan Wanhan 13.38 yuan 44, sodium glass acid eye drops 0.4ml: 1.2mg (0.3%) 24 Yangzijiang Pharmaceuticals 50.4 yuan 45, injection with Bival Luding , 3 enterprises such as Puli Pharmaceuticals won the bid for injection with Bival Luding original research out of the scene, according to the fourth round of centralized drug procurement site understanding, injection with Bivalding 4 bidding enterprises in 3 domestic generic drugs, including Hainan Puli Pharmaceuticals, Qilu Pharmaceuticals, Hainan Shuangcheng.
(Source: Scienceboard Daily) Fosun Pharmaceuticals Subsidiary Winning Bid Sorafini According to the fourth round of drug centralized procurement site exclusively learned that lung cancer target drug Sorafini three bidding enterprises including the original research Bayer, Jiangxi Shanxiang and Fosun Pharmaceutical subsidiary Chongqing Pharmaceutical Friends, the winning bid for two domestic generic pharmaceutical companies, the original research Bayer quoted 5388 yuan (60 tablets), conversion of the price of 90 yuan, due to a limited price reduction.
Soraphini is currently listed in China's two liver cancer first-line targeted drugs, the original research Bayer Solaphini (commodity name: Dojime) in September 2006 into the Chinese market, the current national lowest price is 95 yuan / tablet.
(Source: Science and Technology Board Daily) "Enhua, Hengrui Gaba spray capsule winning bid" According to the fourth round of drug collection site exclusive information, gaba spraying capsule three bidding enterprises, Enhua Pharmaceuticals, Hengrui Pharmaceutical winning bid, Beijing four ring bid.
(Source: Science Board Daily) "Colum Pharmaceuticals and other four enterprises propofol winning bid" According to the fourth round of drug collection site exclusively learned that propofol medium long-chain fat milk injections have Sichuan Colum, Yangzijiang, Jiangsu Yingke and other four enterprises won the bid, a drop of nearly 80%, of which the original research Feisen Yuskabi 9.9 yuan of the lowest price.
(Source: Science Board Daily) "Propofol medium-long-chain fat milk enterprise quotation all revealed" it is understood that the fourth batch of state-owned propofol medium-long-chain fat milk enterprise quotation has been all revealed, a total of 5 enterprises to participate, the original research Feisen Yuscabi offer the lowest 9. 9 yuan, the remaining three generic drug companies have won the bid (Yangzijiang, Colum, Jiangsu Yingke, quoted 14.86, 13.4, 12.5), of which Germany's Belang Medical quotation of the highest 15.5 out.
the winning bid for the injection of the East China Pharmaceutical Subsidiary, the East China Pharmaceutical Subsidiary, and the Winning Bid for the Injection of the East China Anti-Torazole Injection.
The collection of 45 generic drugs in China's urban public hospitals, county-level public hospitals, urban community centers and township hospital terminals total sales of 55 billion yuan in 2019, of which 21 drugs sales exceeded 1 billion yuan, the injection of vitolazole led by 6.67 billion yuan.
the bidding companies for the injection of lutonazole are Takeda, Yangzijiang, Jiangsu Osaikang, Nanjing Zhengda Tianqing, Central and Eastern China and other enterprises.
(Source: Science and Technology Board Daily) The fourth round of national drug collection enterprise declaration dynamics: A total of 126 enterprises (according to the parent company statistics) in the fourth batch of national mining are eligible for the declaration, including 21 foreign-funded enterprises and 105 domestic enterprises, 13 varieties of competitive enterprises more than 5.
(Source: Insight Database) "The fourth round of national drug collection opened in Shanghai today: involving 45 varieties" The fourth round of national drug centralized band procurement opened in Shanghai today (3rd).
this round involves 45 varieties, with a maximum procurement scale of more than 25 billion yuan.
, inhalation preparations were included in the national collection for the first time, and since the official launch of the injection consistency evaluation in May 2020, eight injection varieties, such as the injection of pythonazole, have been included in the collection.
industry analysis, due to the larger market and other reasons, it is expected that several injection varieties of bidding will be more intense.
the market as a whole, there will be more "barefooters" (previously with limited market share) entering the market, or it will also intensify competition.
(Source: ScienceDaily)